ArticleERJ open research2023

AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose study.

Hunter Gillies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.